European Comission
-
European Parliament examines the use of artificial intelligence in healthcare
A recently published Panel for the Future of Science and Technology (STOA) study examines the use of artificial intelligence in healthcare. It explores applications, risks, and ethical and social impacts in the context of the EU member states.
This study offers an overview of how AI can benefit future healthcare, but at the same time it identifies and clarifies the main clinical, social and ethical risks posed by AI in healthcare.… Read more
-
European pharmaceutical strategy goes through data science
On 25 November 2020, the European Commission published its Pharmaceutical Strategy for Europe, which aims to create a futureproof regulatory framework and to support industry in promoting research and new technologies.
This strategy will be based on 4 pillars:
· Ensuring access to affordable drugs for patients, and addressing unmet medical needs.
· Supporting the competitiveness, innovation and sustainability of the EU pharmaceutical industry and the development of high quality, safe, effective and greener medicines.… Read more